Back to search

Article

Humoral Response to BNT162b2 mRNA Covid19 Vaccine in Peritoneal and Hemodialysis Patients: a Comparative Study

2021-06-15

Abstract excerpt

<h4>Introduction</h4> Generalized immunization against COVID19 has become the cornerstone in prevention of severe acute respiratory syndrome associated with this pandemic. Maintenance dialysis patients (MDP) are at higher risk of both exposure and mortality from the disease. Efficacy and security of BNT162b2 vaccine is well documented for the general population, but not in MDP, particularly in peritoneal dialysis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
58988f07-9a59-5c7b-8054-e23a3ab51f47
DOI
10.1101/2021.06.14.21258113
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Humoral Response to BNT162b2 mRNA Covid19 Vaccine in Peritoneal and Hemodialysis Patients: a Comparative StudyDOI 10.1101/2021.06.14.21258113
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on hemodialysisSemantic proximity
Justification, safety, and efficacy of a third dose of mRNA vaccine in maintenance hemodialysis patients: a prospective observational studySemantic proximity
Risk Factors for Low Humoral Response to BNT-162b2 In Hemodialysis PatientsSemantic proximity
Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: cohort studySemantic proximity
Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patientsSemantic proximity
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case seriesSemantic proximity
A Malaysian Study on COVID-19 (SARS-CoV-2) Vaccination Immune Response in Haemodialysis patients: A prospective, multicenter, cohort studySemantic proximity
Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patientsSemantic proximity
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patientsSemantic proximity
Immunity to SARS-CoV-2 in a Dialyzed Patient Who Developed COVID-19 Twenty Days After the Second Dose of BNT162b2 Vaccine: a Case ReportSemantic proximity
Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis PatientsSemantic proximity
Humoral and Cellular Immunogenicity and Safety of 3 Doses of CoronaVac and BNT162b2 in Young Children and Adolescents with Kidney DiseasesSemantic proximity
Select a neighboring publication to make it the new centre.